Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
J Gastrointest Cancer. 2022 Jun;53(2):311-317. doi: 10.1007/s12029-021-00599-w. Epub 2021 Feb 16.
Stomach neoplasms are the fifth common cancer worldwide. The related factors for survival following stomach neoplasms are well-studied; however, information on recurrent events is limited. This study aimed to identify the related factors on recurrent and deaths following stomach neoplasms.
In this cohort study, information on 672 patients with adenocarcinoma who were hospitalized during 1995-2012 was used. Multistate models were applied to determine the effective factors on recurrent and death events.
Median of survival time (months) and 5-year survival was estimated as 24.5 and 25%, respectively. The probability of death was 57% for non-recurrent patients, which increased to 88% among recurrent patients. Hazard of death was 49% lower for females (Hazard Ratio (HR):0.51, P = 0.009) while females had higher hazard of death following recurrent (HR:3.55, P < 0.001). Male patients and those with cardia involvement had higher risk of recurrence. A significant effect of age on the risk of death among patients with and without recurrence was estimated (HR:1.02, 1.03; P = 0.001 for both). Age, cardia involvement, and disease stage are amongst the effective factors on non-recurrent death while complement treatments increased the non-recurrent and recurrent survival.
In patients, effects of some factors for survival may vary throughout the course of disease and depend on recurrence status. We found that while female patients experienced lower recurrence, they had higher risk of death following recurrence. Age, tumor location, and type of therapy were risk factors for non-recurrent death. Finally, tumor location and type of surgery had significant effects on recurrence.
胃癌是全球第五大常见癌症。与胃癌患者生存相关的因素已有大量研究;然而,关于复发事件的信息有限。本研究旨在确定与胃癌患者复发和死亡相关的因素。
在这项队列研究中,使用了 1995 年至 2012 年期间住院的 672 例腺癌患者的信息。应用多状态模型确定与复发和死亡事件相关的有效因素。
中位生存时间(月)和 5 年生存率估计分别为 24.5 和 25%。无复发患者的死亡概率为 57%,而复发患者的死亡概率增加至 88%。女性的死亡风险降低 49%(风险比(HR):0.51,P=0.009),而女性在复发后死亡的风险更高(HR:3.55,P<0.001)。男性患者和贲门受累患者的复发风险更高。估计年龄对有和无复发患者死亡风险的影响具有显著意义(HR:1.02、1.03;P=0.001 均)。年龄、贲门受累和疾病分期是无复发死亡的有效因素,而补充治疗增加了无复发和复发的生存。
在患者中,某些因素对生存的影响可能在疾病过程中有所不同,并取决于复发状态。我们发现,虽然女性患者复发率较低,但复发后死亡风险较高。年龄、肿瘤位置和治疗类型是无复发死亡的危险因素。最后,肿瘤位置和手术类型对复发有显著影响。